Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.

Summary

Digest: The Act tells the State Board of Pharmacy to classify xylazine as a Schedule IV controlled substance. (Flesch Readability Score: 60.1). Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.